Market Research Industry Reports

Innocoll AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Innocoll AG (Innocoll), formerly Innocoll Holdings Plc is a pharmaceutical company that carries out the development and manufacturing of surgical implants and topically applied healthcare products in the areas of unmet clinical needs. The companys pipeline product Xaracoll, a bupivacaine HCl collagen-matrix implant and collagen-based delivery technology has been studied in two Phase III clinical trials for postsurgical analgesia as part of multi-modal therapy for patients undergoing hernia repair. Its Xaracoll has been studied to deliver the anesthetic directly at the surgical site and to reduce pain and opioid use after surgery. The company partners with other pharma companies to market its various products. It operates across the US, Ireland, and Germany. Innocoll is headquartered in Athlone, Ireland.

Innocoll AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.




Innocoll AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Innocoll AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Innocoll AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Innocoll AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Innocoll AG, Medical Devices Deals, 2012 to YTD 2018 9
Innocoll AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Innocoll AG, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
Gurnet Point Acquires Innocoll for USD209 Million 11
Licensing Agreements 13
Innocoll Enters Into Licensing Agreement With Flynn Pharma For CollaGUARD 13
Equity Offering 14
Innocoll Raises USD40 Million in Public Offering of Shares 14
Innocoll Raises USD29.89 million in Public Offering of American Depository Shares 16
Innocoll Raises USD58.5 Million in IPO 17
Innocoll AG - Key Competitors 19
Innocoll AG - Key Employees 20
Innocoll AG - Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Financial Announcements 22
Mar 16, 2017: Innocoll Holdings Announces Fourth Quarter and Full-Year 2016 Financial and Operating Results and Provides Corporate Update 22
Product Approvals 24
Mar 29, 2017: Innocoll announces regulatory path forward after receiving formal FDA Type A meeting minutes regarding its XARACOLL (bupivacaine HCl collagen-matrix implant) New Drug Application 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List Of Tables

List of Tables
Innocoll AG, Pharmaceuticals & Healthcare, Key Facts 2
Innocoll AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Innocoll AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Innocoll AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Innocoll AG, Deals By Therapy Area, 2012 to YTD 2018 8
Innocoll AG, Medical Devices Deals, 2012 to YTD 2018 9
Innocoll AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Gurnet Point Acquires Innocoll for USD209 Million 11
Innocoll Enters Into Licensing Agreement With Flynn Pharma For CollaGUARD 13
Innocoll Raises USD40 Million in Public Offering of Shares 14
Innocoll Raises USD29.89 million in Public Offering of American Depository Shares 16
Innocoll Raises USD58.5 Million in IPO 17
Innocoll AG, Key Competitors 19
Innocoll AG, Key Employees 20
Innocoll AG, Subsidiaries 21

List Of Figures

List of Figures
Trex Company Inc, Performance Chart (2013 - 2017) 26
Trex Company Inc, Ratio Charts 30

Innocoll Holdings Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Innocoll Holdings Company Profile is a detailed strategic and analytical report on Innocoll Holdings. The 2018 version of the report offers detailed insights into the companys strategies, developments, outlook and

USD 200View Report

Innocoll AG - Medical Equipment - Deals and Alliances Profile

Innocoll AG (Innocoll), formerly Innocoll Holdings Plc is a pharmaceutical company that carries out the development and manufacturing of surgical implants and topically applied healthcare products in the areas of

USD 250View Report

Sensile Medical AG - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Sensile Medical AG (Sensile) is a medical device company that develops and produces key technologies for liquid drug delivery devices. The company develops products in the areas of micro insulin

USD 250View Report

B. Braun Melsungen AG - Pharmaceuticals and Healthcare - Deals and Alliances Profile

B. Braun Melsungen AG (B. Braun) develops, manufactures and distributes medical technology and pharmaceutical products, and provides medical services worldwide. The companys major products include solutions and disposables for infusion,

USD 250View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Apr 2018
No. of Pages :25
Country :Ireland
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube